Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALLURION TECHNOLOGIES, INC.ALUR · Entity 8577 | Chief Medical Officer | May 02, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALLURION TECHNOLOGIES, INC.
Report date May 02, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2034-05-01 | Direct | 204,082 |
Reported balance
After 2024-05-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-02 · Grant · Acquired 204,082 · Balance 204,082 F1: 25% of the shares underlying this option vest on May 2, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares underlying this option vest on May 2, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2024 Filed May 7, 2024 00:22 UTC | ALLURION TECHNOLOGIES, INC. ALUR · Entity 8577 | GrantStock Option (Right to Buy) · Derivative | 204,082 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950170-24-053846 · ownership.xml · derivative · entry 1 Chuttani Ram · CIK 0001986858 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,082 Underlying: Common Stock · 204,082 shares Expires 2034-05-01 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on May 2, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.